(Q22252419)

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Autoimmune hemolytic anemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Ganglioside complexes as new target antigens in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Antibody labeling of cholesterol/ceramide ordered domains in cell membranes

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Ganglioside structures and distribution: Are they localized at the nerve ending?

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Anti-Gal-C antibody in autoimmune neuropathies subsequent to mycoplasma infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Combinatorial glycoarray.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Acute motor neuropathy with antibodies to GM1 ganglioside

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Guillain–Barré Syndrome—A Classical Autoimmune Disease Triggered by Infection or Vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Gangliosides: structure, isolation, and analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Autoimmune diseases of the peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Repertoire of human natural anti-glycan immunoglobulins. Do we have auto-antibodies?

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Polysaccharide processing and presentation by the MHCII pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

The Guillain-Barré syndrome: a true case of molecular mimicry

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Mucosal-associated invariant T cells: unconventional development and function

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Anti-ganglioside complex antibodies associated with severe disability in GBS

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Origin of ganglioside complex antibodies in Guillain–Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

BAFF aids generation of IgG anti-ganglioside antibodies in response to Campylobacter jejuni lipo-oligosaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Glycosphingolipid-dependent cross-talk between glycosynapses interfacing tumor cells with their host cells: essential basis to define tumor malignancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Two and three-dimensional pattern recognition of organized surfaces by specific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Antibody responses to glycolipid-borne carbohydrates require CD4+ T cells but not CD1 or NKT cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Campylobacter jejuni: molecular biology and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Guillain–Barré Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

1 reference

7 January 2021

Combinatorial ganglioside biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Peripheral neuropathies and anti-glycolipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Sulfatide binding properties of murine and human antiganglioside antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

IFN-alpha/beta enhances BCR-dependent B cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Immune response, accommodation, and tolerance to transplantation carbohydrate antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Bacterial infections in Guillain-Barré and Fisher syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Ganglioside antibodies and neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Autoantibodies in immune-mediated neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

ABO blood group and related antigens, natural antibodies and transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Immunogenicity of liposomal model membranes

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

The role of GM1 and other gangliosides in neuronal differentiation. Overview and new finding

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

The sialylated lipooligosaccharide outer core in Campylobacter jejuni is an important determinant for epithelial cell invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Multifocal motor neuropathy: serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Novel murine infection models provide deep insights into the "ménage à trois" of Campylobacter jejuni, microbiota and host innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Specificity and cross-reactivity of anti-galactocerebroside antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Phosphoinositide 3-kinase p110 delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021

Sialoadhesin promotes rapid proinflammatory and type I IFN responses to a sialylated pathogen, Campylobacter jejuni

1 reference

https://api.crossref.org/works/10.1016%2FJ.IT.2013.05.001

7 January 2021